13F HOLDINGS REPORT (Amended)
Artia Global Partners LP
Quarter ended Q3 2025 · Filed November 14, 2025 · Accession 0001937964-25-000009
Total Value
$630.9M
Positions
51
Other Managers
0
Confidential Omitted
No
Holdings (51)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | INSMED INC | INSM | 732,212 | $105.4M | 16.71% |
| 2 | ARGENX SE | ARGX | 78,311 | $57.8M | 9.16% |
| 3 | INSMED INC | INSM | 400,000 | $57.6M | 9.13% |
| 4 | SOLENO THERAPEUTICS INC | SLNO | 672,176 | $45.4M | 7.20% |
| 5 | VERONA PHARMA PLC | 925050106 | 379,004 | $40.4M | 6.41% |
| 6 | UNIQURE NV | QURE | 658,839 | $38.5M | 6.10% |
| 7 | MERUS N V | N5749R100 | 296,750 | $27.9M | 4.43% |
| 8 | PROSHARES TR II | 74347W601 | 537,372 | $24.8M | 3.92% |
| 9 | ELI LILLY & CO | LLY | 28,700 | $21.9M | 3.47% |
| 10 | VERTEX PHARMACEUTICALS INC | VRTX | 55,100 | $21.6M | 3.42% |
| 11 | ABIVAX SA | AAVXF | 225,453 | $19.1M | 3.03% |
| 12 | TREVI THERAPEUTICS INC | TRVI | 1,999,702 | $18.3M | 2.90% |
| 13 | BOSTON SCIENTIFIC CORP | BSX | 183,200 | $17.9M | 2.84% |
| 14 | ALNYLAM PHARMACEUTICALS INC | ALNY | 34,570 | $15.8M | 2.50% |
| 15 | QUEST DIAGNOSTICS INC | DGX | 81,717 | $15.6M | 2.47% |
| 16 | ASTRAZENECA PLC | AZN | 190,752 | $14.6M | 2.32% |
| 17 | EYEPOINT PHARMACEUTICALS INC | EYPT | 628,367 | $8.9M | 1.42% |
| 18 | REGENERON PHARMACEUTICALS | REGN | 10,671 | $6.0M | 0.95% |
| 19 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 194,838 | $5.5M | 0.88% |
| 20 | REVOLUTION MEDICINES INC | RVMDW | 104,190 | $4.9M | 0.77% |
| 21 | AVIDITY BIOSCIENCES INC | 05370A108 | 110,100 | $4.8M | 0.76% |
| 22 | ULTRAGENYX PHARMACEUTICAL IN | RARE | 150,000 | $4.5M | 0.72% |
| 23 | DIANTHUS THERAPEUTICS INC | DNTH | 108,723 | $4.3M | 0.68% |
| 24 | IONIS PHARMACEUTICALS INC | IONS | 60,176 | $3.9M | 0.62% |
| 25 | VIKING THERAPEUTICS INC | VKTX | 146,179 | $3.8M | 0.61% |
| 26 | SCHOLAR ROCK HLDG CORP | SRRK | 96,285 | $3.6M | 0.57% |
| 27 | ABBVIE INC | ABBV | 14,500 | $3.4M | 0.53% |
| 28 | NEKTAR THERAPEUTICS | NKTR | 57,999 | $3.3M | 0.52% |
| 29 | CENTESSA PHARMACEUTICALS PLC | CNTA | 133,291 | $3.2M | 0.51% |
| 30 | ASCENDIS PHARMA A/S | ASND | 12,240 | $2.4M | 0.39% |
| 31 | MINERALYS THERAPEUTICS INC | MLYS | 56,600 | $2.1M | 0.34% |
| 32 | UNITED THERAPEUTICS CORP DEL | UTHR | 5,000 | $2.1M | 0.33% |
| 33 | TG THERAPEUTICS INC | TGTX | 54,515 | $2.0M | 0.31% |
| 34 | ULTRAGENYX PHARMACEUTICAL IN | RARE | 64,502 | $1.9M | 0.31% |
| 35 | RAPPORT THERAPEUTICS INC | RAPP | 64,608 | $1.9M | 0.30% |
| 36 | OCULAR THERAPEUTIX INC | OCUL | 141,061 | $1.6M | 0.26% |
| 37 | XENON PHARMACEUTICALS INC | XENE | 40,000 | $1.6M | 0.25% |
| 38 | IREN LIMITED | IREN | 33,200 | $1.6M | 0.25% |
| 39 | PROTAGONIST THERAPEUTICS INC | PTGX | 22,951 | $1.5M | 0.24% |
| 40 | BRIGHTSPRING HEALTH SVCS INC | 10950A106 | 41,600 | $1.2M | 0.19% |
| 41 | BIOHAVEN LTD | BHVN | 80,000 | $1.2M | 0.19% |
| 42 | KINIKSA PHARMACEUTICALS INTL | G52694109 | 29,200 | $1.1M | 0.18% |
| 43 | BRIDGEBIO PHARMA INC | BBIO | 20,400 | $1.1M | 0.17% |
| 44 | MEREO BIOPHARMA GROUP PLC | MREO | 475,361 | $979,244 | 0.16% |
| 45 | SAREPTA THERAPEUTICS INC | SRPT | 44,900 | $865,223 | 0.14% |
| 46 | TRAVERE THERAPEUTICS INC | TVTX | 30,900 | $738,510 | 0.12% |
| 47 | MODERNA INC | MRNA | 23,800 | $614,754 | 0.10% |
| 48 | KALVISTA PHARMACEUTICALS INC | KALV | 41,555 | $506,140 | 0.08% |
| 49 | ATYR PHARMA INC | ATYR | 600,000 | $432,840 | 0.07% |
| 50 | ATYR PHARMA INC | ATYR | 372,276 | $268,560 | 0.04% |
| 51 | ALECTOR INC | ALEC | 71,029 | $210,246 | 0.03% |